Walleye Capital LLC - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 246 filers reported holding KARUNA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.7%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$693,269
-56.2%
4,100
-43.8%
0.00%
-83.3%
Q2 2023$1,583,005
+3.8%
7,300
-13.1%
0.01%
-73.9%
Q1 2023$1,525,776
-54.6%
8,400
-50.9%
0.02%
-62.3%
Q4 2022$3,361,133
+12.3%
17,105
+28.6%
0.06%
+7.0%
Q3 2022$2,992,000
-22.4%
13,300
-56.3%
0.06%
-44.7%
Q1 2022$3,855,00030,4060.10%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$142,043,93358.49%
Nan Fung Group Holdings Ltd 225,688$40,993,96827.90%
Sofinnova Investments, Inc. 1,773,124$322,070,24320.60%
Artia Global Partners LP 88,831$16,135,2635.96%
DAFNA Capital Management LLC 78,573$14,272,0004.28%
First Light Asset Management, LLC 243,675$44,261,1273.98%
CATALYST PRIVATE WEALTH, LLC 21,837$3,966,4732.74%
Sands Capital Ventures, LLC 58,895$10,697,6882.64%
ARCH Venture Management, LLC 30,000$5,449,2002.63%
Logos Global Management LP 100,000$18,164,0002.60%
View complete list of KARUNA THERAPEUTICS INC shareholders